Search for Clinical Trial Results

Sponsored By

Conjunctivitis, Allergic - 14 Studies Found

Status Study
Completed Study Name: Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2011-02-01
Interventions:
  • Drug: Mapracorat administered

Completed Study Name: Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2007-01-17
Interventions:
  • Drug: Bepreve sterile ophthalm
Active, not recruiting Study Name: A Study of ADX-102 in Subjects With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2016-12-14
Interventions:
  • Drug: ADX-102 Ophthalmic Drops (0.5%)

Completed Study Name: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2014-06-09
Interventions:
  • Drug: AGN-229666 One drop of A
Completed Study Name: A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2011-11-09
Interventions:
  • Drug: alcaftadine 0.25% ophthalmic solution

Completed Study Name: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Date: 2013-11-13
Interventions: Drug: Relestat Ophthalmic Solution 0.05% Relestat Ophthalmic Solution 0.05% prescribed as local standard
Completed Study Name: AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2014-03-06
Interventions: Drug: AGN-229666 One to two drops of AGN-229666 twice daily in each eye for 10 weeks.
Recruiting Study Name: Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Condition: Conjunctivitis, Allergic
Date: 2015-09-18
Interventions: Drug: Alcaftadine Ophthalmic Solution 0.25% Alcaftadine Ophthalmic Solution 0.25% (Lastacaft®) as p
Completed Study Name: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Date: 2012-11-19
Interventions:
  • Drug: Alcaftadine 0.25% One dr
Completed Study Name: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Date: 2012-12-04
Interventions:
  • Drug: AL-4943A ophthalmic solution
  • Drug: O
Next >>>